ID: ALA4876498

Max Phase: Preclinical

Molecular Formula: C15H17N3O2

Molecular Weight: 271.32

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCCn1c2ccccc2n2c(C(=O)OC)c(C)nc12

Standard InChI:  InChI=1S/C15H17N3O2/c1-4-9-17-11-7-5-6-8-12(11)18-13(14(19)20-3)10(2)16-15(17)18/h5-8H,4,9H2,1-3H3

Standard InChI Key:  AESMAPYXTQULCX-UHFFFAOYSA-N

Associated Targets(Human)

Transient receptor potential cation channel subfamily M member 2 348 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 271.32Molecular Weight (Monoisotopic): 271.1321AlogP: 2.79#Rotatable Bonds: 3
Polar Surface Area: 48.53Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 4.43CX LogP: 2.22CX LogD: 2.22
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.69Np Likeness Score: -1.36

References

1. Zhao S, Zhang H, Jin H, Cai X, Zhang R, Jin Z, Yang W, Yu P, Zhang L, Liu Z..  (2021)  Design, synthesis and biological activities of benzo[d]imidazo[1,2-a]imidazole derivatives as TRPM2-specfic inhibitors.,  225  [PMID:34416664] [10.1016/j.ejmech.2021.113750]

Source